Pfizer and BioNTech COVID-19 vaccine now 95% effective, to be submitted to FDA ‘within days’
(Worthy News) – Pfizer and BioNTech announced their COVID-19 vaccine candidate is now 95% effective and will soon be submitted to the Food and Drug Administration for emergency use authorization.
On Wednesday, the drugmakers revealed they had completed the third phase of their vaccine and found it to be 95% effective against the coronavirus. The companies said no “serious safety concerns” were observed among the 43,000 people enrolled in the trial, with only 3.8% reporting fatigue and another 2% reporting a headache.
“The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic. We continue to move at the speed of science to compile all the data collected thus far and share with regulators around the world,” said Pfizer CEO Dr. Albert Bourla in a statement. “With hundreds of thousands of people around the globe infected every day, we urgently need to get a safe and effective vaccine to the world.” [ Source: Washington Examiner (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌